Determining phenotypic antimicrobial susceptibilities of Pseudomonas aeruginosa is particularly valuable due to the complexity of resistance mechanisms this organism can harbor. The Accelerate PhenoTest BC kit (AXDX) provides a fast phenotypic antimicrobial susceptibility testing (AST) method for testing P. aeruginosa directly from positive blood culture. This study evaluated updates to the Accelerate PhenoTest BC kit made in order to improve the performance of beta-lactams when tested against P. aeruginosa (1, 2).
No takes yet. Share an insight, caveat, or question.
Sikorski et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: